“All parts of the plant Cannabis sativa L., whether growing or not; the seeds thereof; the resin extracted from any part of such plant; and every compound manufacture, salt, derivative, mixture, or preparation of such plant, its seeds or resins; but shall not include the mature stalks of such plant fiber produced from such stalks oil or cake made from the seeds of such plant, any other compound, manufacture, salt, derivative, mixture, or preparation of such mature stalks (except the resin extracted therefrom),fiber, oil or cake, or the sterilized seed of such plant which is incapable of germination.”
people don’t use CBD for recreational use. it has little to no THC so has no psychoactive properties. many CBD products processed from hemp also do not have enough CBD to affect any medical disorders either. they are just jumping on the trendy CBD bandwagon, like many other so-called “nutritional supplements”. so it is very difficult to find and trust the CBD processed form hemp. useful CBD from hemp can only be processed from the flowers, which is still illegal, even though no THC. the only legal use of hemp in the states is for “industrial” use, only the stalks and seeds (fiber and oil). the stalks and seeds of hemp are so lacking in usable CBD that it is not legitimate for medical use.

Stephanie Kahn, who with her husband, Jeffrey, runs the Takoma Wellness Center, a medical marijuana dispensary in Northwest Washington, says that about half of her 1,200 patients use CBD-rich products. Her dispensary offers several strains of high-CBD cannabis as well as CBD oil, with different ratios of CBD and THC, each of which she recommends for particular conditions. “We get questions about it every day,” she says. “A lot of our patients get relief with this, and a lot of times this works better than pharmaceutical drugs.”
Chronic pain leads to a feeling of despair and hopelessness. One wonders if the pain will ever end? Will I ever get my life back? An unexpected finding during our study was that our patients were coming back to us saying they were hopeful. Instead of their glass being half empty, it was now half full. Hope is powerful. When you have hope, your mind starts to work for you instead of against you. You start to imagine that things can be different. You find the motivation to get off the couch and get busy living instead of waiting to die. This feeling of hope inspired these patients to start engaging in activities we had encouraged them to do for years, like doing yoga, eating healthier, losing weight and moving more.
The Marinol patient monograph cautions that patients should not drive, operate machinery or engage in hazardous activities until accustomed to the drug’s effects (http://www.solvaypharmaceuticals-us.com/static/wma/pdf/1/3/1/9/Marinol5000124ERev52003.pdf). The Sativex product monograph in Canada (http://www.bayerhealth.ca/display.cfm?Object_ID=272&Article_ID=121&expandMenu_ID=53&prevSubItem=5_52) suggests that patients taking it should not drive automobiles. Given that THC is the most active component affecting such abilities, and the low serum levels produced in Sativex therapy (vide supra), it would be logical that that patients may be able to safely engage in such activities after early dose titration and according to individual circumstances, much as suggested for oral dronabinol. This is particularly the case in view of a report by an expert panel (Grotenhermen et al 2005) that comprehensively analyzed cannabinoids and driving. It suggested scientific standards such as roadside sobriety tests, and THC serum levels of 7–10 ng/mL or less, as reasonable approaches to determine relative impairment. No studies have demonstrated significant problems in relation to cannabis affecting driving skills at plasma levels below 5 ng/mL of THC. Prior studies document that 4 rapid oromucosal sprays of Sativex (greater than the average single dose employed in therapy) produced serum levels well below this threshold (Russo 2006b). Sativex is now well established as a cannabinoid agent with minimal psychotropic effect.
Experimental studies have also been conducted in order to assess the effect of cannabis use on schizophrenia. D’Souza et al. (2004) administered varying levels of the main ingredient in cannabis to healthy individuals with a history of cannabis exposure (but not abuse) and found that the subjects in the study displayed both positive and negative symptoms associated with schizophrenia, although all symptoms disappeared by about 3 h. D’Souza et al. (2005) conducted a follow-up study in which they followed the same protocol, but with clinically stable schizophrenia patients. Again, they found brief increases in positive symptoms, even if the patients were already taking antipsychotics.
Cannabidiol (CBD) has NOT been proven to treat, relieve, nor cure any disease or medical condition listed on this site. The medical studies, controlled tests, and health information offered on Cannabidiol Life of allcbdoilbenefits.com (or any variation of the URL) is an expressed summarization of our personal conducted research done by me and few friends in the business. The information provided on this site is designed to support, NEVER replace, the relationship that exists between a patient/site visitor and the patient’s/site visitor’s physician.
Many a time, multiple cannabinoid compounds are used together, either knowingly or unknowingly.  It is, hence, tough to discern the extent to which each compound is involved in causing the desired effect. There are cases where a group of cannabinoids works synergistically in bringing about bodily reactions. Studies selectively employing CBD oil are few in number, but promising.
The leaves, stems, flower buds and extracts from the marijuana plant can be eaten, brewed in a tea or put into a tincture. It can also be vaporized using an e-cigarette pen. Yale University researchers surveyed 3,847 Connecticut high school students about this practice in a 2015 study that was published in the journal Pediatrics. The study found nearly one in five e-cigarette users also have vaporize cannabis or byproducts like hash oil using the device. 
Before purchasing any CBD product in these states (aside from the 8 mentioned above) you must have a medical prescription issued by a certified medical doctor. Each state has a particular concentration of THC it allows to be present in a CBD product, with the percentage ranging from 0.3% — 8%. (See details in table 1.1 below). Even though the legal situation seems to be shifting in a positive direction, if you are in any of these states, it is very important to be aware of the state’s laws towards CBD.
Despite its centrality in human cultures across the globe, the European taxonomists who bequeathed Cannabis sativa its name didn’t quite get it right. When Carolus Linneaus came to naming the marijuana plant’s genus, he thought there was only one species, instead of the three we now know exist. Hence the confusion surrounding the fact that there are three distinct species of the genus Cannabis sativa, one of which is the sativa species.
Given the opioid crisis, physicians are less likely to lead with narcotics, and some of us are deciding not to prescribe them altogether. The problem with narcotics is that they work. They work really well. Sometimes too well, leading to a patient becoming so comfortable they “forget” to breathe. So, while reducing the amount of narcotics prescribed to patients is a good thing, the problem is physicians don’t have a lot of good alternatives to recommend to their patients, until now.

Marijuana can be addictive because it can cause compulsive, uncontrollable drug craving, seeking, and use, even in the face of negative health and social consequences. In 2004, more than 298,317 people entering drug treatment programs reported marijuana as their primary drug of abuse. Some heavy marijuana users show signs of withdrawal when they do not use the drug. They develop symptoms such as restlessness, loss of appetite, trouble sleeping, weight loss, and shaky hands.

I started using hemp oil a week ago…i baked some bite sized pasties today for daily dosea…i put 2 cap fills in my bath also. EVERYTHING HAS CHANGED… my depression is lifting my appetite has lessened I don’t want to sleep all day my sight clearer, skin smoother and face looks less aged. My pain has subsided substantially…i feel like a new person. I am in aww of this amazing life changing product I bought a 32 oz bottle and I use it for everything. Oh ya and my digestion is in way better condition…


The move to Whole Plant extracts will mark an important change in the market as Whole Plant extracts derived from the flowers of the female Hemp plants are able to offer superior Cannabinoid and Terpene profiles as well as higher concentrations of base Cannabinoids, making them similar in composition/concentration to traditional Marijuana Oil extracts derived from illicit Marijuana. A look inside of one of the nations earliest whole plant CBD Hemp pilot programs producing cannabis oil legal for sale may be seen here.

Food and beverage products containing CBD were introduced in the United States in 2017.[53] Similar to energy drinks and protein bars which may contain vitamin or herbal additives, food and beverage items can be infused with CBD as an alternative means of ingesting the substance.[54] In the United States, numerous products are marketed as containing CBD, but in reality contain little or none.[55] Some companies marketing CBD-infused food products with claims that are similar to the effects of prescription drugs have received warning letters from the Food and Drug Administration for making unsubstantiated health claims.[56] In February 2019, the New York City Department of Health announced plans to fine restaurants that sell food or drinks containing CBD, beginning in October 2019.[57]

There are close to four hundred natural compounds in both marijuana and hemp. Understanding the two most prevalent, tetrahydrocannabinol (THC) and cannabidiol (CBD), is the key to understanding the difference between hemp oil and cannabis oil. THC is the cannabinoid responsible for giving a high or ‘stoned’ feeling. CBD, on the other hand, is not psychotropic. Recently it has attracted a lot of attention from researchers, experts, and entrepreneurs.
Ironically, the only four states where you can be absolutely sure that the CBD content claimed on the label is the CBD content in the bottle are Colorado, Washington, Oregon, and Alaska, where adult-use cannabis is legal and regulated. That’s because the CBD products available in licensed retail cannabis stores must pass state-mandated lab tests to assure their purity and potency. In fact, if these products haven’t gone through state testing, they’re liable to be seized, as happened recently in Alaska.
While it’s true that CBD is legal in all 50 states, there are situations when it isn’t legal. The difference between legal and illegal typically depends on several important factors determined by the state in question. There is, however, one very important factor that is a crucial determinant across all states, and that is where the CBD is derived from–hemp or marijuana.

Oral dronabinol (THC) is marketed in synthetic form as Marinol® (Solvay Pharmaceuticals) in various countries, and was approved in the USA for nausea associated with chemotherapy in 1985, and in 1992 for appetite stimulation in HIV/AIDS. Oral dronabinol’s expense, variability of action, and attendant intoxication and dysphoria have limited its adoption by clinicians (Calhoun et al 1998). Two open label studies in France of oral dronabinol for chronic neuropathic pain in 7 subjects (Clermont-Gnamien et al 2002) and 8 subjects (Attal et al 2004), respectively, failed to show significant benefit on pain or other parameters, and showed adverse event frequently requiring discontinuation with doses averaging 15–16.6 mg THC. Dronabinol did demonstrate positive results in a clinical trial of multiple sclerosis pain in two measures (Svendsen et al 2004), but negative results in post-operative pain (Buggy et al 2003) (Table 1). Another uncontrolled case report in three subjects noted relief of intractable pruritus associated with cholestatic jaundice employing oral dronabinol (Neff et al 2002). Some authors have noted patient preference for whole cannabis preparations over oral THC (Joy et al 1999), and the contribution of other components beyond THC to therapeutic benefits (McPartland and Russo 2001). Inhaled THC leads to peak plasma concentration within 3–10 minutes, followed by a rapid fall while levels of intoxication are still rising, and with systemic bioavailability of 10%–35% (Grotenhermen 2004). THC absorption orally is slow and erratic with peak serum levels in 45–120 minutes or longer. Systemic bioavailability is also quite low due to rapid hepatic metabolism on first pass to 11-hydroxy-THC. A rectal suppository of THC-hemisuccinate is under investigation (Broom et al 2001), as are transdermal delivery techniques (Challapalli and Stinchcomb 2002). The terminal half-life of THC is quite prolonged due to storage in body lipids (Grotenhermen 2004).

In this edition of Cannabis Conversations, Project CBD Director, Martin A. Lee, discusses the benefits of CBD, the "entourage effect" and the microbiome with Dr. Ethan Russo. A neurologist, scientist, and widely published author, Dr. Russo is currently the director of research and development at the International Cannabis and Cannabinoids Institute in Prague (www.icci.science).
In a study whose findings have not yet been published, he and a colleague, Daniel Friedman, found that patients receiving CBD in addition to their usual medicines had 39 percent fewer convulsive seizures than patients who remained on their normal drug regimen. Given that the study included only the most treatment-resistant patients, this is an “excellent response,” Devinsky says.
Cannabis is frequently used among Sufis[132] – the mystical interpretation of Islam that exerts strong influence over local Muslim practices in Bangladesh, India, Indonesia, Turkey, and Pakistan. Cannabis preparations are frequently used at Sufi festivals in those countries.[132] Pakistan's Shrine of Lal Shahbaz Qalandar in Sindh province is particularly renowned for the widespread use of cannabis at the shrine's celebrations, especially its annual Urs festival and Thursday evening dhamaal sessions - or meditative dancing sessions.[133][134]
The psychoactive effects of cannabis are known to have a triphasic nature. Primary psychoactive effects include a state of relaxation, and to a lesser degree, euphoria from its main psychoactive compound, tetrahydrocannabinol. Secondary psychoactive effects, such as a facility for philosophical thinking, introspection and metacognition have been reported among cases of anxiety and paranoia.[94] Finally, the tertiary psychoactive effects of the drug cannabis, can include an increase in heart rate and hunger, believed to be caused by 11-OH-THC, a psychoactive metabolite of THC produced in the liver.
Cutting-edge science has shown that the endocannabinoid system is dysregulated in nearly all pathological conditions. Thus, it stands to reason that “modulating endocannabinoid system activity may have therapeutic potential in almost all diseases affecting humans,” as Pal Pacher and George Kunos, scientists with the U.S. National Institutes of Health (NIH), suggested in a 2014 publication.
Despite the fact that Cannabis was grown on a large scale in many countries, the abuse as a narcotic remained uncommon in Western countries until relatively recently. People were largely unaware of the psychoactive properties of Cannabis and it is unlikely that early cultivars, selected mainly for their seed or fiber qualities, contained significant amounts of the psychoactive THC. The medicinal use of Cannabis was introduced in Europe only around 1840, by a young Irish doctor, William O’Shaughnessy, who served for the East India Trading Company in India, where the medicinal use of Cannabis was widespread. Unlike the European fiber Cannabis, these Indian varieties did contain a reasonable amount of bioactive cannabinoids. In the following decades, the medicinal use of Cannabis saw a short period of popularity both in Europe and in the United States. At the top of its popularity, more than 28 different medicinal preparations were available with Cannabis as active ingredient, which were recommended for indications as various as menstrual cramps, asthma, cough, insomnia, support of birth labor, migraine, throat infection, and withdrawal from opium use.27
Cannabinoid agonists produce many effects beyond those mediated directly on receptors, including anti-inflammatory effects and interactions with various other neurotransmitter systems (previously reviewed (Russo 2006a). Briefly stated, THC effects in serotonergic systems are widespread, including its ability to decrease 5-hydroxytryptamine (5-HT) release from platelets (Volfe et al 1985), increase its cerebral production and decrease synaptosomal uptake (Spadone 1991). THC may affect many mechanisms of the trigeminovascular system in migraine (Akerman et al 2003; Akerman et al 2004; Akerman et al 2007; Russo 1998; Russo 2001). Dopaminergic blocking actions of THC (Müller-Vahl et al 1999) may also contribute to analgesic benefits.
CBD can be very pricey, and much of it is sold through multi-level marketing schemes, which I don’t like. Dosing isn’t precise (or well-explained); it would be very helpful to have informed guidance in this area. As it is, I break down any product I buy to cost-per-mg, and cost-per-serving, which helps, but I’m still not sure how much is too much or too little. I tell my husband to “listen to [his] body,” but that can be risky.
While very few clinical trials have explored the pain-relieving effects of CBD oil, a report published in the Cochrane Database of Systematic Reviews in 2018 examined the use of a variety of cannabis-based medicines and found they might be of some benefit in the treatment of chronic neuropathic pain. A type of pain triggered by damage to the somatosensory system (i.e., the system responsible for processing sensory stimuli), neuropathic pain often occurs in people with conditions like diabetes and multiple sclerosis.
Most human studies of CBD have been done on people who have seizures, and the FDA recently approved the first CBD-based drug, Epidiolex, for rare forms of epilepsy. Clinical trials for other conditions are promising, but tiny. In one Brazilian study published in 2011 of people with generalized social anxiety disorder, for example, taking a 600-mg dose of CBD (higher than a typical dose from a tincture) lessened discomfort more than a placebo, but only a dozen people were given the pill.
Cannabidiol (CBD) is a subclass of Phytocannabinoids and one among one twenty cannabis compounds. It is hailed for its ability to be meditative, without causing a euphoric high. This non-addictive miracle cannabinoid has been the talk of the town and the core of numerous experiments. The anti-inflammatory properties of CBD have inspired the marketing of its by-products, such as CBD oil, for pain relief and relaxation.
In this report, researchers reviewed 16 previously published studies testing the use of various cannabis-based medicines in the treatment of chronic neuropathic pain and found some evidence that cannabis-based medicines may help with pain relief and reduce pain intensity, sleep difficulties, and psychological distress. Side effects included sleepiness, dizziness, mental confusion. The authors concluded that the potential harm of such medicines may outweigh their possible benefit, however, it should be noted that the studies used a variety of cannabis-based medicines (e.g. inhaled cannabis and sprays and oral tablets containing THC and/or CBD from plant sources or made synthetically), some of which are more likely to result in these side effects than products without THC.

Hemp Oil

×